Comparative Efficacy of Coral Calcium Carried Hydrogen versus Dexamethasone in a Mouse Model of Allergic Contact Dermatitis.
Gaoxiang Huang, Dongmei Wei, Wei Zhao, Hao Xu, Yankang Wang, Xinyao Fu, Ye Yang, Rong Li, Xuzhen Wang, Kai Zhou, Jing Luan · Journal of inflammation research · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In female BALB/c mice, there were no significant differences in dissolved hydrogen concentrations between 5 mg/mL and 10 mg/mL CCH solutions. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in female BALB/c mice. There were no significant differences in dissolved hydrogen concentrations between 5 mg/mL and 10 mg/mL CCH solutions.
What the Researchers Studied
The researchers studied female BALB/c mice. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Following preparation of CCH solutions with varying concentration gradients, dissolved hydrogen levels were quantified at predetermined intervals (2, 4, 6, 8, 10, 12, 24, 48 hours post-preparation) using a calibrated portable hydrogen analyzer (ENH-2000, Trustlex, Japan). There were no significant differences in dissolved hydrogen concentrations between 5 mg/mL and 10 mg/mL CCH solutions. The therapeutic potential of hydrogen in skin inflammation is underpinned by its well-documented anti-oxidative and anti-inflammatory properties, which are highly relevant to the pathophysiology of ACD. Speculatively, the sustained hydrogen release from CCH likely mitigated ACD by alleviating oxidative stress via selective ROS scavenging.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was female BALB/c mice. The study used a preclinical animal experiment.
Limitations and Safety
Reported limitations: 19–22 However, its clinical application is limited by physicochemical challenges, such as rapid diffusion due to low molecular weight, poor aqueous solubility and transient biological activity.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.